NU2GGH002515
Cooperative Agreement
Overview
Grant Description
Strengthening Brazil's response to HIV and other infectious diseases through prevention, treatment, care, laboratory, strategic information, epidemiology, and surveillance activities under the President's Emergency Plan for AIDS Relief (PEPFAR).
In Brazil, the emergence of the AIDS epidemic coincided with public health reformulations, definitions of guidelines, and discussions on health reform, originating from the Unified Health System, which provided universal, equitable, and comprehensive access to health services.
Thus, the country has been aligned with global recommendations and promoted efforts to develop HIV surveillance, prevention, and control actions since the outbreak of the epidemic.
HIV infection in Brazil has affected specific population segments.
That is, while the detection rate of the virus in the general population is 0.4%, this rate is 18.4% in gay men and other men who have sex with men; around 31.2% in transsexual women and transvestites; 5.9% in sex workers and around 5% in people who inject drugs.
Given the gaps in the Brazilian HIV cascade, this five-year award aims to support:
(I) the expanded HIV and sexually transmitted infections diagnosis among key and more vulnerable populations;
(II) linkage to care and immediate treatment for all individuals;
(III) the expanded information and dissemination of combined prevention in Brazil; and
(IV) the promotion of governance, health system strengthening, strategic information, community leadership, and communication outreach to support project implementation.
The strategies aimed at the HIV/AIDS program and their respective activities will be developed in the five municipalities that PEPFAR has already supported: Campo Grande, Curitiba, Florianópolis, Fortaleza, Porto Alegre, and other municipalities in the north and southeast of Brazil that will be included throughout this COAG.
Besides, this proposal aims to support the Brazilian government in responding to other public health emergencies and global health threats.
The award will build on twenty years of collaboration between the United States Centers for Disease Control and Prevention, the Oswaldo Cruz Foundation, and the Foundation for Scientific and Technological Development in Health.
Together they will continue the implementation of new and innovative strategies aimed at the prevention, diagnosis, and immediate treatment of HIV/AIDS and other sexually transmitted infections, focusing on key and most vulnerable populations.
This COAG will also continue supporting services in screening and treating tuberculosis and other opportunistic infections for clients living with HIV and pursuing the active search for users who are interrupting or stopping treatment.
Expected outcomes among the key and most vulnerable populations served in the target areas include increased PrEP and PEP uptake among high-risk populations; improved case-finding and active linkage of key and most vulnerable populations; improved detection of STI among key populations; improved early detection of active tuberculosis cases, referral to treatment, and timely access to HIV testing services; improved early detection and treatment of opportunistic infections among PLHIV; increased access to care in primary care services by eligible PLHIV; improved engagement of transgender population within health services; improved HIV retention services and treatment adherence; increased screening, case-detection, and treatment of active tuberculosis among PLHIV; increased access to HIV services by migrant populations and people in prisons; decreased stigma and discrimination against key populations.
In Brazil, the emergence of the AIDS epidemic coincided with public health reformulations, definitions of guidelines, and discussions on health reform, originating from the Unified Health System, which provided universal, equitable, and comprehensive access to health services.
Thus, the country has been aligned with global recommendations and promoted efforts to develop HIV surveillance, prevention, and control actions since the outbreak of the epidemic.
HIV infection in Brazil has affected specific population segments.
That is, while the detection rate of the virus in the general population is 0.4%, this rate is 18.4% in gay men and other men who have sex with men; around 31.2% in transsexual women and transvestites; 5.9% in sex workers and around 5% in people who inject drugs.
Given the gaps in the Brazilian HIV cascade, this five-year award aims to support:
(I) the expanded HIV and sexually transmitted infections diagnosis among key and more vulnerable populations;
(II) linkage to care and immediate treatment for all individuals;
(III) the expanded information and dissemination of combined prevention in Brazil; and
(IV) the promotion of governance, health system strengthening, strategic information, community leadership, and communication outreach to support project implementation.
The strategies aimed at the HIV/AIDS program and their respective activities will be developed in the five municipalities that PEPFAR has already supported: Campo Grande, Curitiba, Florianópolis, Fortaleza, Porto Alegre, and other municipalities in the north and southeast of Brazil that will be included throughout this COAG.
Besides, this proposal aims to support the Brazilian government in responding to other public health emergencies and global health threats.
The award will build on twenty years of collaboration between the United States Centers for Disease Control and Prevention, the Oswaldo Cruz Foundation, and the Foundation for Scientific and Technological Development in Health.
Together they will continue the implementation of new and innovative strategies aimed at the prevention, diagnosis, and immediate treatment of HIV/AIDS and other sexually transmitted infections, focusing on key and most vulnerable populations.
This COAG will also continue supporting services in screening and treating tuberculosis and other opportunistic infections for clients living with HIV and pursuing the active search for users who are interrupting or stopping treatment.
Expected outcomes among the key and most vulnerable populations served in the target areas include increased PrEP and PEP uptake among high-risk populations; improved case-finding and active linkage of key and most vulnerable populations; improved detection of STI among key populations; improved early detection of active tuberculosis cases, referral to treatment, and timely access to HIV testing services; improved early detection and treatment of opportunistic infections among PLHIV; increased access to care in primary care services by eligible PLHIV; improved engagement of transgender population within health services; improved HIV retention services and treatment adherence; increased screening, case-detection, and treatment of active tuberculosis among PLHIV; increased access to HIV services by migrant populations and people in prisons; decreased stigma and discrimination against key populations.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Brazil
Geographic Scope
Foreign
Related Opportunity
CDC-RFA-GH-23-0028
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/29/28 to 09/29/29 and the total obligations have increased 201% from $1,240,435 to $3,735,500.
Fiotec - Fundacao Para O Desenvolvimento Cientifico E Tecnologico Em Saude was awarded
Enhancing Brazil's HIV Response & Infectious Disease Control: PEPFAR
Cooperative Agreement NU2GGH002515
worth $3,735,500
from Center for Global Health in September 2024 with work to be completed primarily in Brazil.
The grant
has a duration of 5 years and
was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance.
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
9/30/24
Start Date
9/29/29
End Date
Funding Split
$3.7M
Federal Obligation
$0.0
Non-Federal Obligation
$3.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU2GGH002515
Additional Detail
Award ID FAIN
NU2GGH002515
SAI Number
NU2GGH002515-4172136566
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CW00 CDC CENTER FOR GLOBAL HEALTH
Awardee UEI
H8YMGVK36S97
Awardee CAGE
00UDK
Performance District
Not Applicable
Modified: 9/26/25